Thank you for sharing!

Your article was successfully shared with the contacts you provided.

This fall, the Supreme Court will hear argument in Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. relating to generic versions of Teva’s multiple sclerosis drug, Copaxone®. This case deserves close attention for its potential to affect interpretation and enforcement of patent rights, patent litigation strategies, and ultimately, patent value.

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2017 ALM Media Properties, LLC. All Rights Reserved.